MAS
52
-4
ETR
65
2
SRE
63
2
PEP
39
-9
CNX
73
-3
TMO
42
-6
JNPR
50
-6
WM
74
-5
RL
69
-4
VRSN
53
-5
SNA
70
-5
CAT
59
-2
STZ
52
-6
USB
50
-3
JWN
48
-2
RSG
65
-3
PSA
56
3
PDCO
29
2
DFS
64
2
HRL
35
-3
MAS
52
-4
ETR
65
2
SRE
63
2
PEP
39
-9
CNX
73
-3
TMO
42
-6
JNPR
50
-6
WM
74
-5
RL
69
-4
VRSN
53
-5
SNA
70
-5
CAT
59
-2
STZ
52
-6
USB
50
-3
JWN
48
-2
RSG
65
-3
PSA
56
3
PDCO
29
2
DFS
64
2
HRL
35
-3
Financhill
Back

Conductor Global Equity Value ETF Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
48

CGV
Conductor Global Equity Value ETF

Last Price:
12.79
Seasonality Move:
2.67%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
48
Conductor Global Equity Value ETF (CGV) is a Sell

Is Conductor Global Equity Value ETF a Buy, Sell or Hold?

  • The current Conductor Global Equity Value ETF [CGV] share price is $12.75. The Score for CGV is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • CGV is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CGV Stock Price Chart

What is Conductor Global Equity Value ETF's stock price today?

  • The Conductor Global Equity Value ETF share price today is $12.75
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CGV is experiencing selling pressure, which indicates risk of future bearish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

CGV Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.13 Sell
Relative Strength Index (14 RSI): 31.36 Sell
Chaikin Money Flow: -10082 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (12.97 - 13.39) Sell
Bollinger Bands (100): (12.85 - 13.43) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

CGV Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 13 Sell
20-day SMA: 13.1 Sell
50-day SMA: 13.29 Sell
200-day SMA: 13.12 Sell
8-day EMA: 12.94 Sell
20-day EMA: 13.08 Sell
50-day EMA: 13.18 Sell
200-day EMA: 13.13 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

Conductor Global Equity Value ETF Earnings Growth & CGV Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

Conductor Global Equity Value ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):